Home / Sweden / Oncopeptides AB
Oncopeptides AB
Short position disclosed on August 11, 2026.
1.30% of the capital sold short
1 disclosing funds
437 disclosures on record
SE0009414576 ISIN code
Evolution of the disclosed total
0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
July 23, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| GSA Capital Partners LLP | 1.30% | new | August 11, 2026 |
On the other side: the funds that hold Oncopeptides AB Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 14, 2020 | Voleon Capital Management LP | 0.82% | still open |
| May 12, 2020 | Voleon Capital Management LP | 0.71% | still open |
| May 6, 2020 | Voleon Capital Management LP | 0.63% | still open |
| April 29, 2020 | Voleon Capital Management LP | 0.89% | still open |
| April 23, 2020 | Voleon Capital Management LP | 0.99% | still open |
| April 9, 2020 | Voleon Capital Management LP | 1.09% | still open |
| April 7, 2020 | Voleon Capital Management LP | 1.15% | still open |
| March 31, 2020 | Voleon Capital Management LP | 1.20% | still open |
| March 20, 2020 | Voleon Capital Management LP | 1.13% | still open |
| March 17, 2020 | Voleon Capital Management LP | 1.06% | still open |
| March 16, 2020 | Voleon Capital Management LP | 1.18% | still open |
| March 10, 2020 | Voleon Capital Management LP | 1.22% | still open |
| March 6, 2020 | Voleon Capital Management LP | 1.12% | still open |
| March 2, 2020 | Voleon Capital Management LP | 1.01% | still open |
| February 26, 2020 | Voleon Capital Management LP | 0.91% | still open |
| February 20, 2020 | Voleon Capital Management LP | 0.80% | still open |
| February 7, 2020 | Voleon Capital Management LP | 0.79% | still open |
| January 30, 2020 | Voleon Capital Management LP | 0.80% | still open |
| January 17, 2020 | Voleon Capital Management LP | 0.70% | still open |
| January 9, 2020 | Voleon Capital Management LP | 0.69% | still open |
| January 2, 2020 | Voleon Capital Management LP | 0.77% | still open |
| December 16, 2019 | Voleon Capital Management LP | 0.90% | still open |
| December 15, 2019 | Voleon Capital Management LP | 0.90% | still open |
| December 10, 2019 | Voleon Capital Management LP | 0.80% | still open |
| December 9, 2019 | Voleon Capital Management LP | 0.80% | still open |
| December 3, 2019 | Voleon Capital Management LP | 0.77% | still open |
| December 2, 2019 | Voleon Capital Management LP | 0.80% | still open |
| December 1, 2019 | Voleon Capital Management LP | 0.80% | still open |
| November 28, 2019 | Voleon Capital Management LP | 0.75% | still open |
| November 27, 2019 | Voleon Capital Management LP | 0.75% | still open |
| November 26, 2019 | Voleon Capital Management LP | 0.60% | still open |
| November 25, 2019 | Voleon Capital Management LP | 0.60% | still open |
| November 20, 2019 | Voleon Capital Management LP | 0.50% | still open |
| November 19, 2019 | Voleon Capital Management LP | 0.50% | still open |
| July 25, 2018 | Worldquant, LLC | 0.00% | still open |
| July 24, 2018 | WorldQuant, LLC | 0.51% | still open |
| July 23, 2018 | WorldQuant, LLC | 0.51% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Oncopeptides AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/oncopeptides-ab?page=9